Stock DNA
Capital Markets
USD 111,252 Million (Large Cap)
29.00
NA
1.49%
-999,999.00
28.31%
7.06
Total Returns (Price + Dividend) 
Marsh & McLennan Cos., Inc. for the last several years.
Risk Adjusted Returns v/s 
News
Is Marsh & McLennan Cos., Inc. overvalued or undervalued?
As of 31 October 2025, the valuation grade for Marsh & McLennan Cos., Inc. moved from fair to expensive, indicating that the stock is overvalued. Key valuation ratios reveal a P/E ratio of 29, a Price to Book Value of 8.96, and an EV to EBITDA of 17.47, all suggesting a premium valuation relative to its peers. In comparison, Aon Plc has a P/E of 29.25 and Arthur J. Gallagher & Co. has a significantly higher P/E of 45.99, further emphasizing Marsh & McLennan's elevated valuation. Recent stock performance shows that Marsh & McLennan has underperformed against the S&P 500 across multiple periods, with a year-to-date return of -15.02% compared to the S&P 500's 16.30%. This underperformance, coupled with its expensive valuation metrics, reinforces the conclusion that the company is currently overvalued....
Read MoreIs Marsh & McLennan Cos., Inc. overvalued or undervalued?
As of 31 October 2025, the valuation grade for Marsh & McLennan Cos., Inc. moved from fair to expensive, indicating that the company is overvalued. The key ratios highlight this position, with a P/E ratio of 29, a Price to Book Value of 8.96, and an EV to EBITDA of 17.47. Comparatively, peers such as Aon Plc and Arthur J. Gallagher & Co. have P/E ratios of 29.25 and 45.99, respectively, suggesting that Marsh & McLennan is trading at a premium relative to some competitors. Additionally, the company's stock has underperformed against the S&P 500 across multiple time frames, with a year-to-date return of -16.61% compared to the S&P 500's 16.30%. This trend reinforces the notion that the stock is overvalued in the current market environment....
Read MoreIs Marsh & McLennan Cos., Inc. overvalued or undervalued?
As of 31 October 2025, the valuation grade for Marsh & McLennan Cos., Inc. has moved from fair to expensive. The company appears to be overvalued based on its current metrics. Key ratios include a P/E ratio of 29, a Price to Book Value of 8.96, and an EV to EBITDA of 17.47. In comparison, peers such as Aon Plc have a P/E of 29.25 and Arthur J. Gallagher & Co. has a significantly higher P/E of 45.99, indicating that Marsh & McLennan is trading at a premium relative to some competitors. The company's recent stock performance has been underwhelming, with a year-to-date return of -16.13% compared to the S&P 500's return of 16.30%, reinforcing the notion that the stock may be overvalued in the current market environment....
Read More Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2025
Shareholding Compare (%holding) 
Domestic Funds
Held in 177 Schemes (40.67%)
Held by 493 Foreign Institutions (22.78%)
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
QoQ Growth in quarter ended Jun 2025 is -1.20% vs 16.95% in Mar 2025
QoQ Growth in quarter ended Jun 2025 is -12.82% vs 76.28% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 7.28% vs 9.45% in Dec 2023
YoY Growth in year ended Dec 2024 is 8.29% vs 23.16% in Dec 2023






